Haleon (HLN) Gains from Investment Securities (2022 - 2023)
Haleon (HLN) recorded quarterly Gains from Investment Securities of $8.7 million in Q4 2023, up 346.91% on a QoQ basis from -$3.5 million in Q4 2022, and up 346.91% year-over-year from $1.9 million in Q4 2022.
Haleon (HLN) Gains from Investment Securities (2022 - 2023) Analysis & Trends
Haleon has disclosed Gains from Investment Securities across 2 years of filings, most recently posting $8.7 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Haleon | 1.09 Bn | -776.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 8.69 Mn |
| Dec 31, 2023 | 8.69 Mn |
| Dec 31, 2022 | -3.52 Mn |
| Dec 31, 2022 | -3.52 Mn |